During the past decade, Hematology Dpt, Hôpital Sud Francilien conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Dpt, Hôpital Sud Francilien" #1 collaborator was "Celgene" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Dpt, Hôpital Sud Francilien" are "Myelodysplastic Syndromes" (2 trials). Many other conditions were trialed in "Hematology Dpt, Hôpital Sud Francilien" in a lesser frequency.

Most popular intervention types in "Hematology Dpt, Hôpital Sud Francilien" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin beta" (1 trials), "Lenalidomide" (1 trials) and "VORINOSTAT" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Dpt, Hôpital Sud Francilien" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hematology Dpt, Hôpital Sud Francilien". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Hematology Dpt, Hôpital Sud Francilien, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Dpt, Hôpital Sud Francilien, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".